| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2001 | CA2379356A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 02/22/2001 | CA2379168A1 Chimeric dna/rna ribozymes containing propanediol |
| 02/22/2001 | CA2378708A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | CA2377637A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/22/2001 | CA2377415A1 An oral administration form |
| 02/22/2001 | CA2377133A1 Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 02/21/2001 | EP1077217A2 Neuroactive peptides and their use |
| 02/21/2001 | EP1077213A2 Inhibition of serotonin reuptake |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1077069A1 Preventives/remedies for hepatic cirrhosis |
| 02/21/2001 | EP1077067A1 Stabilized cefuroxime axetil |
| 02/21/2001 | EP1077061A2 Use of peroxidised lipids for treating or preventing mucosal wounds and inflammations of the oral cavity |
| 02/21/2001 | EP1076723A2 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 02/21/2001 | EP1076718A1 Novel method for preparing synthesis intermediates |
| 02/21/2001 | EP1076691A1 Cellular and animal models for diseases associated with altered mitochondrial function |
| 02/21/2001 | EP1076659A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
| 02/21/2001 | EP1076658A1 Serotonergic agents |
| 02/21/2001 | EP1076652A1 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 02/21/2001 | EP1076651A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 02/21/2001 | EP1076650A1 Aryl fused azapolycyclic compounds |
| 02/21/2001 | EP1076647A2 Antipsychotic indolyl derivatives |
| 02/21/2001 | EP1076645A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 02/21/2001 | EP1076644A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/21/2001 | EP1076643A1 Biphenyl derivatives |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP1076569A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 02/21/2001 | EP1076562A1 Glucocorticoid receptor antagonists for the treatment of dementia |
| 02/21/2001 | EP1076561A2 Combination therapy for the treatment of tumors |
| 02/21/2001 | EP1076560A1 Inhibition of protein kinases with piridinylimidazoles |
| 02/21/2001 | EP1076559A2 Cabergoline and pramipexole for treating cns diseases, especially parkinson's disease |
| 02/21/2001 | EP1076558A1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens |
| 02/21/2001 | EP1076557A1 Ccr-3 receptor antagonists |
| 02/21/2001 | EP1076556A1 Administration of resveratrol to prevent or treat restenosis following coronary intervention |
| 02/21/2001 | EP1076553A2 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
| 02/21/2001 | EP0983242A4 Method for producing particles of pyrithione salts |
| 02/21/2001 | EP0975609A4 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/21/2001 | EP0734382B1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | CN1284987A Soap bars with bactericidal capacity and methods of enhancing such capacity |
| 02/21/2001 | CN1284959A Process for purifying solution of ampicillin pro-drug ester |
| 02/21/2001 | CN1284958A Metallocorrinoids as biologically compatible carriers of pharmocological agents |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284956A Novel bispidine antiarrhythmic compounds |
| 02/21/2001 | CN1284955A 整联蛋白受体拮抗剂 Integrin receptor antagonists |
| 02/21/2001 | CN1284954A Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 02/21/2001 | CN1284953A Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 02/21/2001 | CN1284952A Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 02/21/2001 | CN1284951A Triazine compounds for treatment of CNS disorders |
| 02/21/2001 | CN1284950A Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 02/21/2001 | CN1284948A Indezole bioisostere replacement of catechol in therafeutically active compounds |
| 02/21/2001 | CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/21/2001 | CN1284946A Substituted isoquinoline derivatives and their use as anticonvulsants |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284943A Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284941A Novel antiarrhythmic compounds |
| 02/21/2001 | CN1284883A Method to enhance an immune response of nucleic acid vaccination |
| 02/21/2001 | CN1284880A Hyperhydrated citicoline, process and use |
| 02/21/2001 | CN1284879A Method for preventing abuse of opioid dosage forms |
| 02/21/2001 | CN1284878A Drugs augmenting NKT cells |
| 02/21/2001 | CN1284877A Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
| 02/21/2001 | CN1284875A Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 02/21/2001 | CN1284874A 5-HT1F agonists |
| 02/21/2001 | CN1284873A Water-base liquid preparation |
| 02/21/2001 | CN1284872A Treatment agent |
| 02/21/2001 | CN1284871A compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| 02/21/2001 | CN1284870A Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 02/21/2001 | CN1284869A Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 02/21/2001 | CN1284868A Oral pharmaceutical pulsed release dosage form |
| 02/21/2001 | CN1284866A Oral pharmaceutical extended release dosage form |
| 02/21/2001 | CN1284865A Pharmaceutical compositions containing micronized bicyclic drugs |
| 02/21/2001 | CN1284864A Novel formulation for use in pain management |
| 02/21/2001 | CN1284863A Topical compositions for NSAI drug delivery |
| 02/21/2001 | CN1284862A Topical compositions for prostaglandin E1 delivery |
| 02/21/2001 | CN1284861A Novel pharmaceutical compositions of uridine triphosphate |
| 02/21/2001 | CN1284505A Azabicyclic compound |
| 02/21/2001 | CN1284494A Bamboo parasitic fungus extract and its preparation and application |
| 02/21/2001 | CN1284369A Tinea pedis eliminating medicine |
| 02/21/2001 | CN1284366A Preparation of life prolonging preparation |
| 02/21/2001 | CN1284365A Fracture treating plaster |
| 02/21/2001 | CN1284360A Tibeten medicine for treating hepatitis B and its preparation |
| 02/21/2001 | CN1284354A Enteritis curing capsule |
| 02/21/2001 | CN1284346A Far infrared Gukangtie plaster |
| 02/21/2001 | CN1284341A Immune regulator of amino acid calcium from turtle shell and its preparation |
| 02/21/2001 | CN1284337A Piles medicine |
| 02/21/2001 | CN1284334A Medicinal composition for treating AlDS |
| 02/21/2001 | CN1284333A Application of isopropylfuran in preparing hepatitis B virus resisting medicine |
| 02/21/2001 | CN1284332A Onychomycosis cream and its production process |
| 02/21/2001 | CN1284331A Application of 5,3',5'-trihydroxy-methoxyl dihydroflavone in preparing medicine |
| 02/21/2001 | CN1284330A Medicinal aerosol preparation, its preparing method and release |
| 02/21/2001 | CN1284327A Composition for making unstable material of oxygen stabilize |
| 02/21/2001 | CN1284325A Composition for treating scurf, psoriasis and eczema |
| 02/21/2001 | CN1062269C Novel (R)-5-carbamyl-8-fluoro-3-N, N-disubstituted amino-3, 4-dihydro-2H-1-benzopyranes |
| 02/21/2001 | CN1062263C Semicarbazones having CNS activity and pharmaceutical preparations containing same |
| 02/21/2001 | CN1062182C Novel physiologically active substance |
| 02/21/2001 | CN1062162C External use ointment for treatment of cutaneous pigmentation |
| 02/21/2001 | CN1062156C Drug for preventing and treating tinea, smelly foot and infections skin disease |